230 related articles for article (PubMed ID: 25975019)
1. [The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system].
He F; Cao L; Zhang XJ; Xiang B; Cao DY; Qi XR
Yao Xue Xue Bao; 2015 Feb; 50(2):141-7. PubMed ID: 25975019
[TBL] [Abstract][Full Text] [Related]
2. [Activatable cell-penetrating peptides: a potential activatable modality for diseases diagnosis and therapy].
Yang SK; Yan X; Sun WH; Du Q; Xiang B; Cao DY; Qi XR
Yao Xue Xue Bao; 2016 Apr; 51(4):529-35. PubMed ID: 29859520
[TBL] [Abstract][Full Text] [Related]
3. Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.
MacEwan SR; Chilkoti A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):31-48. PubMed ID: 22977001
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
[TBL] [Abstract][Full Text] [Related]
5. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
6. Rational design of CPP-based drug delivery systems: considerations from pharmacokinetics.
Mickan A; Sarko D; Haberkorn U; Mier W
Curr Pharm Biotechnol; 2014; 15(3):200-9. PubMed ID: 25312539
[TBL] [Abstract][Full Text] [Related]
7. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
[TBL] [Abstract][Full Text] [Related]
8. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
Zhang Q; Gao H; He Q
Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
[TBL] [Abstract][Full Text] [Related]
9. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides.
Aguilera TA; Olson ES; Timmers MM; Jiang T; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):371-81. PubMed ID: 20023744
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
Dissanayake S; Denny WA; Gamage S; Sarojini V
J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
[TBL] [Abstract][Full Text] [Related]
12. Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos.
Kristensen M; Birch D; Mørck Nielsen H
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840305
[TBL] [Abstract][Full Text] [Related]
13. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
Feni L; Neundorf I
Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
[TBL] [Abstract][Full Text] [Related]
15. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
16. Progress in tumour-targeted drug delivery based on cell-penetrating peptides.
Kong X; Xu J; Yang X; Zhai Y; Ji J; Zhai G
J Drug Target; 2022 Jan; 30(1):46-60. PubMed ID: 33944641
[TBL] [Abstract][Full Text] [Related]
17. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides.
Bolhassani A; Jafarzade BS; Mardani G
Peptides; 2017 Jan; 87():50-63. PubMed ID: 27887988
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
[TBL] [Abstract][Full Text] [Related]
20. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
